[{"Assets_0_Q3_USD":15828000.0,"CommonStockSharesOutstanding_0_Q3_shares":22791066.0,"NetIncomeLoss_1_Q3_USD":-5995000.0,"NetIncomeLoss_3_Q3_USD":-19618000.0,"StockholdersEquity_0_Q3_USD":-4813000.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]